by Bruce Sylvester: Treatment of recurrent Clostridium difficile infection with oral, frozen and encapsulated fecal material from unrelated donors has resulted in a 90 percent rate of resolution… read more.
by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab), a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.
by Bruce Sylvester – Compared to no screening, flexible sigmoidoscopy screening has resulted in a reduced incidence of colorectal cancer and rate of death from colorectal cancer, researchers… read more.
World Congress on Gastrointestinal Cancer (WCGC) meeting, Barcelona 25 – 28 June 2014.
Report from the Joint International Congress of ILTS, ELITA and LICAGE 2014. Roger Williams, Institute of Hepatology/Foundation for Liver Research, London, UK. Medical care after acute liver failure… read more.
by Thomas R. Collins – A retrospective study of over 224,000 patients who underwent over 314,000 colonoscopies indicates that pre-cancerous adenoma detection tracks the future risk of colorectal… read more.
by Bruce Sylvester: A study published on Feb. 27, 2014 in The Lancet suggests that amyotrophic lateral sclerosis (ALS) patients who are mildly obese are more likely to… read more.
by Bruce Sylvester – Long-term treatment with some prescription heartburn and ulcer medications appears to be related to an increased risk of vitamin B12 deficiency, researchers reported on… read more.
Solange M Sanches et al, AC Camargo Cancer Center, São Paulo, Brazil.
Discussion of the abstract by Dr Christopher Lieu, MD, Assistant professor at the University of Colorado. Younger patients with colorectal cancer that has spread (metastasised) to other parts… read more.
Birgitte Pedersen et al, Vejle Hospital, Denmark. Patients with colorectal cancer (CRC) face huge challenges in their everyday lives as a result of their condition and treatments.
Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
